Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
NYSE:PBH

Prestige Consumer Healthcare - PBH Stock Forecast, Price & News

$60.43
+0.05 (+0.08%)
(As of 11/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$59.99
$60.66
50-Day Range
$48.72
$60.90
52-Week Range
$48.51
$63.47
Volume
234,493 shs
Average Volume
266,761 shs
Market Capitalization
$2.99 billion
P/E Ratio
14.67
Dividend Yield
N/A
Price Target
$68.75

Prestige Consumer Healthcare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
13.8% Upside
$68.75 Price Target
Short Interest
Healthy
2.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
0.29mentions of Prestige Consumer Healthcare in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
5.73%
From $4.19 to $4.43 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Consumer Discretionary Sector

170th out of 273 stocks

Pharmaceutical Preparations Industry

279th out of 509 stocks

PBH stock logo

About Prestige Consumer Healthcare (NYSE:PBH) Stock

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Stock News Headlines

Factors Working Well for Prestige Consumer
Holding Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc
See More Headlines
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Company Calendar

Last Earnings
11/04/2021
Today
11/28/2022
Next Earnings (Estimated)
2/02/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
CUSIP
74112D10
Employees
505
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$68.75
High Stock Price Forecast
$71.00
Low Stock Price Forecast
$63.00
Forecasted Upside/Downside
+13.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$205.38 million
Pretax Margin
23.83%

Debt

Sales & Book Value

Annual Sales
$1.09 billion
Cash Flow
$4.84 per share
Book Value
$31.43 per share

Miscellaneous

Free Float
48,734,000
Market Cap
$2.99 billion
Optionable
Optionable
Beta
0.55

Key Executives

  • Mr. Ronald M. LombardiMr. Ronald M. Lombardi (Age 58)
    Chairman, Pres & CEO
    Comp: $2.73M
  • Ms. Christine Sacco (Age 46)
    Chief Financial Officer
    Comp: $1.26M
  • Mr. Jeffrey Zerillo (Age 61)
    Sr. VP of Operations
    Comp: $580.88k
  • Mr. William C. P'Pool (Age 57)
    Sr. VP, Gen. Counsel & Corp. Sec.
    Comp: $955.34k
  • Mr. Adel Mekhail (Age 61)
    Exec. VP of Marketing & Sales
    Comp: $971.47k
  • Mr. Philip David Terpolilli
    Director of Investor Relations
  • Dean Siegal
    Director of Communications
  • Ms. Mary Beth Fritz
    Sr. VP of Quality & Regulatory Affairs













PBH Stock - Frequently Asked Questions

Should I buy or sell Prestige Consumer Healthcare stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PBH shares.
View PBH analyst ratings
or view top-rated stocks.

What is Prestige Consumer Healthcare's stock price forecast for 2023?

5 equities research analysts have issued 1-year price targets for Prestige Consumer Healthcare's shares. Their PBH share price forecasts range from $63.00 to $71.00. On average, they predict the company's stock price to reach $68.75 in the next year. This suggests a possible upside of 13.8% from the stock's current price.
View analysts price targets for PBH
or view top-rated stocks among Wall Street analysts.

How have PBH shares performed in 2022?

Prestige Consumer Healthcare's stock was trading at $60.65 on January 1st, 2022. Since then, PBH stock has decreased by 0.4% and is now trading at $60.43.
View the best growth stocks for 2022 here
.

When is Prestige Consumer Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our PBH earnings forecast
.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) posted its quarterly earnings data on Thursday, November, 4th. The company reported $1.02 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.03. The company earned $276.23 million during the quarter, compared to the consensus estimate of $261.23 million. Prestige Consumer Healthcare had a net margin of 18.83% and a trailing twelve-month return on equity of 12.88%. Prestige Consumer Healthcare's quarterly revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.78 EPS.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare issued an update on its FY 2023 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of $4.18-$4.23 for the period, compared to the consensus earnings per share estimate of $4.20. The company issued revenue guidance of $1.12 billion-$1.13 billion, compared to the consensus revenue estimate of $1.12 billion.

What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO?

8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA).

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (17.01%), Vanguard Group Inc. (11.40%), Dimensional Fund Advisors LP (7.18%), State Street Corp (3.93%), Macquarie Group Ltd. (3.88%) and Massachusetts Financial Services Co. MA (2.51%). Insiders that own company stock include Mary Beth Fritz and Ronald M Lombardi.
View institutional ownership trends
.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $60.43.

How much money does Prestige Consumer Healthcare make?

Prestige Consumer Healthcare (NYSE:PBH) has a market capitalization of $2.99 billion and generates $1.09 billion in revenue each year. The company earns $205.38 million in net income (profit) each year or $4.12 on an earnings per share basis.

How many employees does Prestige Consumer Healthcare have?

The company employs 505 workers across the globe.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The official website for the company is www.prestigebrands.com. The company can be reached via phone at (914) 524-6800, via email at irinquiries@prestigebrands.com, or via fax at 302-674-5266.

This page (NYSE:PBH) was last updated on 11/28/2022 by MarketBeat.com Staff